| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 698148 | Null | 0.0385203205529756 | -0.21564192 |
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0396077140933377 | -0.21640512 |
| NSC 129757 | Null | 0.0396077140933377 | 0.14661772 |
| NSC 154948 | M-AMSA | 0.0396077140933377 | 0.22744152 |
| NSC 164991 | Null | 0.0396077140933377 | 0.063552671 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0396077140933377 | -0.066391887 |
| NSC 185065 | Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- | 0.0396077140933377 | -0.13033605 |
| NSC 18805 | .gamma.-Thujaplicine | 0.0396077140933377 | -0.056833901 |
| NSC 244404 | Null | 0.0396077140933377 | -0.17505898 |
| NSC 275647 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- | 0.0396077140933377 | 0.18764001 |